Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Current status and future directions in induction chemotherapy for head and neck cancer.

Argiris A.

Crit Rev Oncol Hematol. 2013 Oct;88(1):57-74. doi: 10.1016/j.critrevonc.2013.03.001. Epub 2013 Mar 27. Review.

PMID:
23541071
2.

Combination of taxanes, cisplatin and fluorouracil as induction chemotherapy for locally advanced head and neck cancer: a meta-analysis.

Qin H, Luo J, Zhu YP, Xie HL, Yang WQ, Lei WB.

PLoS One. 2012;7(12):e51526. doi: 10.1371/journal.pone.0051526. Epub 2012 Dec 7.

3.

Induction chemotherapy before chemoradiotherapy in locally advanced head and neck cancer: the future?

Paccagnella A, Mastromauro C, D'Amanzo P, Ghi MG.

Oncologist. 2010;15 Suppl 3:8-12. doi: 10.1634/theoncologist.2010-S3-08.

4.

Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer.

Posner MR, Hershock DM, Blajman CR, Mickiewicz E, Winquist E, Gorbounova V, Tjulandin S, Shin DM, Cullen K, Ervin TJ, Murphy BA, Raez LE, Cohen RB, Spaulding M, Tishler RB, Roth B, Viroglio Rdel C, Venkatesan V, Romanov I, Agarwala S, Harter KW, Dugan M, Cmelak A, Markoe AM, Read PW, Steinbrenner L, Colevas AD, Norris CM Jr, Haddad RI; TAX 324 Study Group.

N Engl J Med. 2007 Oct 25;357(17):1705-15.

5.

Adjusting for patient selection suggests the addition of docetaxel to 5-fluorouracil-cisplatin induction therapy may offer survival benefit in squamous cell cancer of the head and neck.

Pignon JP, Syz N, Posner M, Olivares R, Le Lann L, Yver A, Dunant A, Lewin F, Dalley DN, Paccagnella A, Taylor SG, Domenge C, Bourhis J, Mazumdar M.

Anticancer Drugs. 2004 Apr;15(4):331-40.

PMID:
15057136
6.

Induction chemotherapy with TPF (Docetaxel, Carboplatin and Fluorouracil) in the treatment of locally advanced squamous cell carcinoma of the head and neck.

Schultz JD, Bran G, Anders C, Sadick H, Faber A, Hörmann K, Sauter A.

Oncol Rep. 2010 Nov;24(5):1213-6.

PMID:
20878112
7.

Induction chemotherapy for head and neck cancer: recent data.

Vokes EE.

Oncologist. 2010;15 Suppl 3:3-7. doi: 10.1634/theoncologist.2010-S3-03. Review.

8.

Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer.

Vermorken JB, Remenar E, van Herpen C, Gorlia T, Mesia R, Degardin M, Stewart JS, Jelic S, Betka J, Preiss JH, van den Weyngaert D, Awada A, Cupissol D, Kienzer HR, Rey A, Desaunois I, Bernier J, Lefebvre JL; EORTC 24971/TAX 323 Study Group.

N Engl J Med. 2007 Oct 25;357(17):1695-704.

9.

[Taxan induction chemotherapy and concomitant chemoradiotherapy with cisplatin in patients with locally advanced head and neck cancer--early results].

Chilimoniuk M, Olszewska E, Maksimowicz T.

Pol Merkur Lekarski. 2010 Dec;29(174):357-60. Polish.

PMID:
21298984
10.

Docetaxel in the management of patients with head and neck squamous cell carcinoma.

Bernier J, Vrieling C.

Expert Rev Anticancer Ther. 2008 Jul;8(7):1023-32. doi: 10.1586/14737140.8.7.1023. Review.

PMID:
18588449
11.

Emerging drugs for head and neck cancer.

Haddad R, Wirth L, Posner M.

Expert Opin Emerg Drugs. 2006 Sep;11(3):461-7. Review.

PMID:
16939385
12.
13.

Phase II study of induction and adjuvant chemotherapy for squamous cell carcinoma of the head and neck. A long-term analysis for the Illinois Cancer Center.

Athanasiadis I, Taylor S 4th, Vokes EE, Pelzer HJ, Rademaker A, Mittal BB, Ganzenko N, Blough R, Lester EP, Kies MS.

Cancer. 1997 Feb 1;79(3):588-94.

PMID:
9028372
14.

Efficacy and safety of dose-modified docetaxel plus cisplatin-based induction chemotherapy in Asian patients with locally advanced head and neck cancer.

Huang CE, Lu CH, Chen PT, Chan CH, Chen WC, Wang WH, Wu JY, Kuan FC, Lee KD, Chen CC.

J Clin Pharm Ther. 2012 Jun;37(3):342-7. doi: 10.1111/j.1365-2710.2011.01306.x. Epub 2011 Sep 26.

PMID:
21950487
15.

Rate of pathologic complete responses to docetaxel, cisplatin, and fluorouracil induction chemotherapy in patients with squamous cell carcinoma of the head and neck.

Haddad R, Tishler R, Wirth L, Norris CM, Goguen L, Sullivan C, O'Donnell L, Li Y, Posner M.

Arch Otolaryngol Head Neck Surg. 2006 Jun;132(6):678-81.

PMID:
16785415
16.

[Induction chemotherapy for locally advanced head and neck cancer].

Calais G, Chapet S, Ruffier-Loubière A, Bernadou G.

Cancer Radiother. 2013 Oct;17(5-6):498-501. doi: 10.1016/j.canrad.2013.06.038. Epub 2013 Sep 4. French.

PMID:
24011601
17.

Phase III trial of initial chemotherapy in stage III or IV head and neck cancers: a study by the Gruppo di Studio sui Tumori della Testa e del Collo.

Paccagnella A, Orlando A, Marchiori C, Zorat PL, Cavaniglia G, Sileni VC, Jirillo A, Tomio L, Fila G, Fede A, et al.

J Natl Cancer Inst. 1994 Feb 16;86(4):265-72.

PMID:
8158680
18.

Induction therapy in the modern era of combined-modality therapy for locally advanced head and neck cancer.

Posner M, Vermorken JB.

Semin Oncol. 2008 Jun;35(3):221-8. doi: 10.1053/j.seminoncol.2008.03.007. Review.

PMID:
18544437
20.

Docetaxel, cisplatin, and 5-fluorouracil-based induction chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck: the Dana Farber Cancer Institute experience.

Haddad R, Colevas AD, Tishler R, Busse P, Goguen L, Sullivan C, Norris CM, Lake-Willcutt B, Case MA, Costello R, Posner M.

Cancer. 2003 Jan 15;97(2):412-8.

Supplemental Content

Support Center